These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 30568606)

  • 1. Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia.
    MacKenzie NE; Kowalchuk C; Agarwal SM; Costa-Dookhan KA; Caravaggio F; Gerretsen P; Chintoh A; Remington GJ; Taylor VH; Müeller DJ; Graff-Guerrero A; Hahn MK
    Front Psychiatry; 2018; 9():622. PubMed ID: 30568606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cognition, schizophrenia and the effect of antipsychotics].
    Stip E
    Encephale; 2006; 32(3 Pt 1):341-50. PubMed ID: 16840928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible dose-side effect relationship of antipsychotic drugs: relevance to cognitive function in schizophrenia.
    Sumiyoshi T
    Expert Rev Clin Pharmacol; 2008 Nov; 1(6):791-802. PubMed ID: 24410608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using an Integrated Care Pathway for Late-Life Schizophrenia Improves Monitoring of Adverse Effects of Antipsychotics and Reduces Antipsychotic Polypharmacy.
    Abdool PS; Supasitthumrong T; Patel K; Mulsant BH; Rajji TK
    Am J Geriatr Psychiatry; 2019 Jan; 27(1):84-90. PubMed ID: 30396766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Schizophrenia, diabetes mellitus and antipsychotics].
    Gury C
    Encephale; 2004; 30(4):382-91. PubMed ID: 15538314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefit-risk assessment of atypical antipsychotics in the treatment of schizophrenia and comorbid disorders in children and adolescents.
    Toren P; Ratner S; Laor N; Weizman A
    Drug Saf; 2004; 27(14):1135-56. PubMed ID: 15554747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive functioning following discontinuation of antipsychotic medication. A naturalistic sub-group analysis from the OPUS II trial.
    Albert N; Randers L; Allott K; Jensen HD; Melau M; Hjorthøj C; Nordentoft M
    Psychol Med; 2019 May; 49(7):1138-1147. PubMed ID: 30058511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive function in schizophrenia. Deficits, functional consequences, and future treatment.
    Sharma T; Antonova L
    Psychiatr Clin North Am; 2003 Mar; 26(1):25-40. PubMed ID: 12683258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive effects and antipsychotic treatment.
    Kasper S; Resinger E
    Psychoneuroendocrinology; 2003 Jan; 28 Suppl 1():27-38. PubMed ID: 12504070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-emergent metabolic syndrome in patients with schizophrenia receiving atypical (second-generation) antipsychotics.
    Gautam S; Meena PS
    Indian J Psychiatry; 2011 Apr; 53(2):128-33. PubMed ID: 21772644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotics in the treatment of schizophrenia: an overview.
    Tandon R
    J Clin Psychiatry; 2011; 72 Suppl 1():4-8. PubMed ID: 22217436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The longitudinal course of cognitive impairment in schizophrenia: an examination of data from premorbid through posttreatment phases of illness.
    Keefe RS
    J Clin Psychiatry; 2014; 75 Suppl 2():8-13. PubMed ID: 24919165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diabetes and second-generation (atypical) antipsychotics].
    Chabroux S; Haffen E; Penfornis A
    Ann Endocrinol (Paris); 2009 Sep; 70(4):202-10. PubMed ID: 19700142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits and limits of anticholinergic use in schizophrenia: focusing on its effect on cognitive function.
    Ogino S; Miyamoto S; Miyake N; Yamaguchi N
    Psychiatry Clin Neurosci; 2014 Jan; 68(1):37-49. PubMed ID: 24102938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herbal Therapies for Weight Gain and Metabolic Abnormalities Induced by Atypical Antipsychotics: A Review Article.
    Naghibi H; Salari R; Yousefi M; Khadem-Rezaiyan M; Ghanbarzadeh MR; Fayyazi Bordbar MR
    Curr Drug Discov Technol; 2023; 20(5):e110423215660. PubMed ID: 37055899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
    Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.